Supplier News

Sep 20, 2018
By Pharmaceutical Technology Editors
The company will be presenting at CPhI Worldwide on Oct. 11, 2018.
Sep 20, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 19, 2018
By Pharmaceutical Technology Editors
Evonik completed a EUR 36 million expansion of its contract-manufacturing capabilities for API and advanced intermediates in the United States and Germany.
Sep 19, 2018
By Pharmaceutical Technology Editors
PCI Pharma Services and CSP Technologies will partner on protective packaging solutions for clinical trials and stability testing.
Sep 19, 2018
By Pharmaceutical Technology Editors
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.
Sep 19, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The companies have partnered to launch Conjugated Polymer Nanoparticle (CPN) products for use in molecular imaging and R&D applications.
Sep 18, 2018
By Pharmaceutical Technology Editors
The $425-million acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.
Sep 17, 2018
By Pharmaceutical Technology Editors
Guenter Nadler, director of business development at Aptar Pharma, will present an insight briefing on new drug-delivery trends in treating upper and lower respiratory tract issues on Tuesday, Oct. 9, 2018 at CPhI Worldwide.
Sep 17, 2018
By Pharmaceutical Technology Editors
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
native1_300x100
lorem ipsum